Quest 10 Wealth Builders’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41K Buy
33
+2
+6% +$89 ﹤0.01% 663
2026
Q1
$1.49K Buy
31
+6
+24% +$280 ﹤0.01% 662
2025
Q4
$1.21K Sell
25
-26
-51% -$1.29K ﹤0.01% 614
2025
Q3
$2.41K Buy
51
+23
+82% +$1.11K ﹤0.01% 598
2025
Q2
$1.35K Sell
28
-2
-7% -$102 ﹤0.01% 612
2025
Q1
$1.66K Buy
30
+2
+7% +$108 ﹤0.01% 571
2024
Q4
$1.35K Buy
+28
New +$1.42K ﹤0.01% 632

Other funds holding SNY

Quest 10 Wealth Builders's SNY Position: Q2 2026 in Review

Quest 10 Wealth Builders increased its Sanofi (SNY) stake by 6.5% in Q2 2026, buying an estimated $89 and bringing the position to 33 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Quest 10 Wealth Builders first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.41K in Q3 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Quest 10 Wealth Builders held 33 shares of Sanofi worth $1.41K as of Q2 2026.
  • Quest 10 Wealth Builders bought 2 Sanofi shares in Q2 2026, an estimated $89.
  • Sanofi made up ﹤0.01% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #663 holding.
  • Quest 10 Wealth Builders first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • Quest 10 Wealth Builders's Sanofi position peaked at $2.41K in Q3 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.